Personalized Oncology in Surgery and Transplantation
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Precision Oncology".
Deadline for manuscript submissions: 25 February 2027 | Viewed by 110
Special Issue Editors
2. N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
Interests: surgery; surgical oncology; minimally invasive surgery; transplantation; molecular oncology
Special Issues, Collections and Topics in MDPI journals
Interests: surgery; hepatocellular carcinoma; targeted therapies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Personalized oncology has evolved into a patient-centered paradigm integrating risk assessment, biomarker-driven strategies, and tailored decision-making. While established in systemic therapies, its translation into surgical oncology and transplantation remains a rapidly developing area. Advances in imaging, artificial intelligence (AI), and immunotherapy are reshaping this landscape, particularly in transplant oncology, where integrating oncologic and immunological data is essential for individualized therapeutic pathways.
This Special Issue examines how personalized medicine can be implemented in surgical and transplant oncology, shifting from generalized protocols to patient-specific strategies. Key areas of interest include:
- Integration of molecular/clinical biomarkers and radiomics into surgical decision-making.
- Personalized selection criteria for oncologic surgery and transplantation (e.g., HCC beyond conventional criteria).
- Managing malignancies in transplant recipients and using organs from donors with treated tumors.
- Tailored immunosuppressive strategies and immunotherapy in transplant settings.
- AI and predictive modeling for staging and treatment response evaluation.
The main objectives are to promote individualized risk stratification and explore strategies combining molecular profiling with real-time clinical decisions. This Special Issue welcomes original research articles, systematic reviews, and other types that provide novel insights into personalized oncologic care, particularly work bridging experimental findings with real-world practice.
Researchers and clinicians are warmly invited to contribute high-quality work focusing on biomarker-driven interventions, AI-based prediction, and emerging concepts in transplant oncology. By fostering interdisciplinary collaboration, we aim to provide a dynamic platform for redefining standards of care in complex oncologic scenarios. We look forward to your contributions in shaping the future of personalized surgery and transplantation.
Dr. Christos Damaskos
Dr. Nikolaos Garmpis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized oncology
- precision medicine
- individualized treatment
- transplant oncology
- post-transplant malignancy
- surgical oncology
- organ transplantation
- donor-derived malignancy
- biomarker-driven therapy
- imaging
- immunosup-pression
- cancer recurrence
- risk stratification
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
